Enhanced General Purpose Centrifuge Product Line Increases Capacity and Flexibility
New enhanced general purpose centrifuge product line offers clinical and life science researchers the ability to spin more samples in a single run while maximizing critical lab space.
The Thermo Scientific general purpose centrifuges feature increased capacity and flexibility with rotor innovations including the new Thermo Scientific TX-1000 rotor, which is the only rotor on the market that employs a 4-L capacity in a traditional 3-L footprint. In addition, the new Thermo Scientific MicroClick 30 x 2 rotor offers a 30-place capacity for microtube and nucleic acid spin columns, and is ideal for molecular biology applications. These high-capacity rotors are designed to process more tubes in fewer runs, saving time while reducing energy and wear on the centrifuge.
“Clinical and life science researchers using a general purpose centrifuge are always looking to save time, space and money while increasing productivity,” said Maurizio Merli, global product director, centrifugation, for Thermo Fisher Scientific. “Our latest rotor innovations address researchers’ needs by allowing them to spin more samples in one run for increased production without surrendering space, performance or flexibility.”
The Thermo Scientific general purpose centrifuge line is designed for a wide range of clinical and life science applications, from cell culture to bioproduction to proteomics, food safety, pharmaceutical, stem cell, microbiology and genomics. The general purpose centrifuge floor models conserve valuable bench space with an almost 25% smaller footprint compared to refrigerated benchtop models and a working height of 79 cm, providing true ergonomic design for removing tubes and exchanging rotors.
The new rotor innovations in the general purpose centrifuge line offer a number of features and benefits:
• TX-1000 rotor: • Up to 40 X 50 mL conical tubes, 196 blood tubes or 24 microplates
• Advanced lubricant and corrosion resistant coating
• Dual-purpose large bucket design accepts adapters for tubes or microplates
• MicroClick 30 x 2 rotor: • High 30-place volume for 1.5/2.0 mL microtube and nucleic acid spin columns
• ClickSeal biocontainment lid for quick and easy sample access.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance